Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Epizyme, Inc. EPZM |
Palo Alto Investors LP | 0 0.000% |
-5,485,213 (Position Closed) |
Filing History |
| 2022-09-08 4:01 pm Sale |
2022-08-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 0 0.000% |
-15,598,934 (Position Closed) |
Filing History |
| 2022-08-12 7:32 pm Sale |
2022-08-12 | 13D | Archaea Energy Inc. LFG |
Ipsen S.A. | 1,000 100.000% |
-34,418,711 (-100.00%) |
Filing History |
| 2022-08-09 4:01 pm Purchase |
2022-07-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,598,934 9.270% |
251,157 (+1.64%) |
Filing History |
| 2022-07-07 4:57 pm Purchase |
2022-06-27 | 13D | Archaea Energy Inc. LFG |
Ipsen S.A. | 34,419,711 20.500% |
34,419,711 (New Position) |
Filing History |
| 2022-06-28 08:32 am Purchase |
2022-06-27 | 13D | Epizyme, Inc. EPZM |
RPI Finance Trust | 34,419,711 20.600% |
52,216 (+0.15%) |
Filing History |
| 2022-02-14 5:11 pm Sale |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
Palo Alto Investors LP | 5,485,213 5.280% |
-1,253,700 (-18.60%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
Redmile Group LLC | 3,832,475 3.500% |
-6,392,930 (-62.52%) |
Filing History |
| 2022-02-10 11:56 am Sale |
2022-01-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,347,777 9.430% |
-18,700 (-0.12%) |
Filing History |
| 2022-02-10 08:11 am Sale |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
The Vanguard Group | 5,984,908 5.760% |
-1,580,339 (-20.89%) |
Filing History |
| 2022-02-09 5:22 pm Purchase |
2022-01-31 | 13G | Epizyme, Inc. EPZM |
BLACKROCK INC BLK |
7,797,036 4.800% |
181,388 (+2.38%) |
Filing History |
| 2022-02-08 2:03 pm Purchase |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,366,477 14.790% |
157,950 (+1.04%) |
Filing History |
| 2022-02-07 06:12 am Purchase |
2022-01-31 | 13D | Epizyme, Inc. EPZM |
HUTCHMED (China) Ltd | 5,653,000 3.400% |
5,653,000 (New Position) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
BLACKROCK INC BLK |
7,615,648 7.300% |
-295,380 (-3.73%) |
Filing History |
| 2022-02-01 4:45 pm Purchase |
2022-01-31 | 13D | Epizyme, Inc. EPZM |
RPI Finance Trust | 34,367,495 21.100% |
22,700,828 (+194.58%) |
Filing History |
| 2021-08-16 07:20 am Purchase |
2021-08-07 | 13D | HUTCHMED (China) Limited HCM |
HUTCHMED (China) Ltd | 5,653,000 5.200% |
5,653,000 (New Position) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Epizyme, Inc. EPZM |
Palo Alto Investors LP | 6,738,913 6.630% |
592,968 (+9.65%) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Epizyme, Inc. EPZM |
Redmile Group LLC | 10,225,405 9.900% |
1,088,032 (+11.91%) |
Filing History |
| 2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,208,527 14.970% |
140,100 (+0.93%) |
Filing History |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Epizyme, Inc. EPZM |
The Vanguard Group | 7,565,247 7.450% |
758,914 (+11.15%) |
Filing History |